Can Neuropathic Screening Tools Be Used As Outcome Measures?

Pain Medicine

Volumn 12, Issue 2, 2011, Pages 276-281

  Searle, Robert D ^a   Bennett, Michael I ^b   Tennant, Alan ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

LANSS; Neuropathic Pain; Outcome Measure; Rasch

Indexed keywords

ARTICLE; CHRONIC DISEASE; CHRONIC PAIN; CLINICAL ASSESSMENT; COMPUTER PROGRAM; DIABETIC NEUROPATHY; GENDER; GROUPS BY AGE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTTRAUMATIC COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RASCH ANALYSIS; RELIABILITY; SCREENING;

EID: 79751502092     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.01037.x     Document Type: Article

References (18)

1. Finnerup NB, Sindrup SH, Jensen TS. Chronic neuropathic pain: Mechanisms, drug targets and measurement. Fundam Clin Pharmacol 2007;21(2):129-36.
2. Bennett M. The LANSS pain scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001;92(1-2):147-57.
3. Bennett MI, Smith BH, Torrance N, Lee AJ. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 2006;122(3):289-94.
4. Solak O, Metin M, Esme H, etal. Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain. Eur J Cardiothorac Surg 2007;32(1):9-12.
5. Khedr EM, Kotb H, Kamel NF, etal. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005;76(6):833-8.
6. Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: Study of 40 consecutive cases. Curr Med Res Opin 2009;25(11):2737-43.
7. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004;7(suppl 1):S22-6.
8. Pesudovs K, Noble BA. Improving subjective scaling of pain using Rasch analysis. J Pain 2005;6(9):630-6.
9. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper. Arthritis Rheum 2007;57(8):1358-62.
10. Hans G, Masquelier E, De Cock P. The diagnosis and management of neuropathic pain in daily practice in Belgium: An observational study. BMC Public Health 2007;7:170.
11. Fisher JW. Reliability statistics. Rasch Meas Trans 1992;6(3):238.
12. Smith EV Jr. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002;3(2):205-31.
13. Wright B. Separation, reliability and skewed distributions. Rasch Meas Trans 2001;14:786.
14. Decruynaere C, Thonnard JL, Plaghki L. Measure of experimental pain using Rasch analysis. Eur J Pain 2007;11(4):469-74.
15. Decruynaere C, Thonnard JL, Plaghki L. How many response levels do children distinguish on faces scales for pain assessment. Eur J Pain 2009;13(6):641-8.
16. Bennett MI, Attal N, Backonja MM, etal. Using screening tools to identify neuropathic pain. Pain 2007;127(3):199-203.
17. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 1997;48(2):332-8.
18. Waterman C, Victor TW, Jensen MP, etal. The assessment of pain quality: An item response theory analysis. J Pain 2010;11(3):273-9.